カテゴリ： 世界, 医療/バイオ, QYResearch

プリン作動性受容体拮抗薬の世界市場2023年：P2Y、P2X

■ 英語タイトル：Global Purinergic Receptor Antagonists Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8630）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8630
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：86
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[プリン作動性受容体拮抗薬の世界市場2023年：P2Y、P2X]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はプリン作動性受容体拮抗薬のグローバル市場について調査・分析し、世界のプリン作動性受容体拮抗薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（P2Y、P2X）、用途別セグメント分析（心臓病、脳卒中、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Sanofi、Bristol Myers Squibb、Apotex、Mylan、AstraZeneca、Chiesi Farmaceutici、Bayer、Zydus Cadila Healthcare、Sun Pharmaceutical、Huahai Pharmaceuticalなどが含まれています。プリン作動性受容体拮抗薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、プリン作動性受容体拮抗薬市場規模を算出する際に考慮しました。

・プリン作動性受容体拮抗薬市場の概要
- プリン作動性受容体拮抗薬の種類別セグメント
- 世界のプリン作動性受容体拮抗薬市場規模：タイプ別分析（P2Y、P2X）
- プリン作動性受容体拮抗薬の用途別セグメント
- 世界のプリン作動性受容体拮抗薬市場規模：用途別分析（心臓病、脳卒中、その他）
- 世界のプリン作動性受容体拮抗薬市場規模予測（2018年-2029年）

・プリン作動性受容体拮抗薬市場の成長トレンド
- プリン作動性受容体拮抗薬の地域別市場規模（2018年-2029年）
- プリン作動性受容体拮抗薬市場ダイナミクス
- プリン作動性受容体拮抗薬の業界動向
- プリン作動性受容体拮抗薬市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：P2Y、P2X
- 世界のプリン作動性受容体拮抗薬のタイプ別市場規模（2018年-2023年）
- 世界のプリン作動性受容体拮抗薬のタイプ別市場規模（2024年-2029年）

・用途別セグメント：心臓病、脳卒中、その他
- 世界のプリン作動性受容体拮抗薬の用途別市場規模（2018年-2023年）
- 世界のプリン作動性受容体拮抗薬の用途別市場規模（2024年-2029年）

・プリン作動性受容体拮抗薬の地域別市場規模
- 北米のプリン作動性受容体拮抗薬市場規模（2018年-2029年）
- 米国のプリン作動性受容体拮抗薬市場規模（2018年-2029年）
- ヨーロッパのプリン作動性受容体拮抗薬市場規模（2018年-2029年）
- アジア太平洋のプリン作動性受容体拮抗薬市場規模（2018年-2029年）
- 中国のプリン作動性受容体拮抗薬市場規模（2018年-2029年）
- 日本のプリン作動性受容体拮抗薬市場規模（2018年-2029年）
- 韓国のプリン作動性受容体拮抗薬市場規模（2018年-2029年）
- インドのプリン作動性受容体拮抗薬市場規模（2018年-2029年）
- オーストラリアのプリン作動性受容体拮抗薬市場規模（2018年-2029年）
- 中南米のプリン作動性受容体拮抗薬市場規模（2018年-2029年）
- 中東・アフリカのプリン作動性受容体拮抗薬市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Sanofi、Bristol Myers Squibb、Apotex、Mylan、AstraZeneca、Chiesi Farmaceutici、Bayer、Zydus Cadila Healthcare、Sun Pharmaceutical、Huahai Pharmaceutical

・アナリストの観点/結論

・調査手法と情報源

Drugs That Bind to Purine Receptors and Block Their Activation, Thereby Inhibiting Platelets, Are Mostly Used to Reduce the Risk of Heart Disease and Stroke in High-risk Groups.
Highlights
The global Purinergic Receptor Antagonists market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Purinergic Receptor Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Purinergic Receptor Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Purinergic Receptor Antagonists in Heart Disease is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Purinergic Receptor Antagonists include Sanofi, Bristol Myers Squibb, Apotex, Mylan, AstraZeneca, Chiesi Farmaceutici, Bayer, Zydus Cadila Healthcare and Sun Pharmaceutical, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Purinergic Receptor Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Purinergic Receptor Antagonists.
The Purinergic Receptor Antagonists market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Purinergic Receptor Antagonists market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Purinergic Receptor Antagonists companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Sanofi
Bristol Myers Squibb
Apotex
Mylan
AstraZeneca
Chiesi Farmaceutici
Bayer
Zydus Cadila Healthcare
Sun Pharmaceutical
Huahai Pharmaceutical
Segment by Type
P2Y
P2X
Segment by Application
Heart Disease
Stroke
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Purinergic Receptor Antagonists companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Purinergic Receptor Antagonists Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 P2Y
1.2.3 P2X
1.3 Market by Application
1.3.1 Global Purinergic Receptor Antagonists Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Heart Disease
1.3.3 Stroke
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Purinergic Receptor Antagonists Market Perspective (2018-2029)
2.2 Purinergic Receptor Antagonists Growth Trends by Region
2.2.1 Global Purinergic Receptor Antagonists Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Purinergic Receptor Antagonists Historic Market Size by Region (2018-2023)
2.2.3 Purinergic Receptor Antagonists Forecasted Market Size by Region (2024-2029)
2.3 Purinergic Receptor Antagonists Market Dynamics
2.3.1 Purinergic Receptor Antagonists Industry Trends
2.3.2 Purinergic Receptor Antagonists Market Drivers
2.3.3 Purinergic Receptor Antagonists Market Challenges
2.3.4 Purinergic Receptor Antagonists Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Purinergic Receptor Antagonists Players by Revenue
3.1.1 Global Top Purinergic Receptor Antagonists Players by Revenue (2018-2023)
3.1.2 Global Purinergic Receptor Antagonists Revenue Market Share by Players (2018-2023)
3.2 Global Purinergic Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Purinergic Receptor Antagonists Revenue
3.4 Global Purinergic Receptor Antagonists Market Concentration Ratio
3.4.1 Global Purinergic Receptor Antagonists Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Purinergic Receptor Antagonists Revenue in 2022
3.5 Purinergic Receptor Antagonists Key Players Head office and Area Served
3.6 Key Players Purinergic Receptor Antagonists Product Solution and Service
3.7 Date of Enter into Purinergic Receptor Antagonists Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Purinergic Receptor Antagonists Breakdown Data by Type
4.1 Global Purinergic Receptor Antagonists Historic Market Size by Type (2018-2023)
4.2 Global Purinergic Receptor Antagonists Forecasted Market Size by Type (2024-2029)
5 Purinergic Receptor Antagonists Breakdown Data by Application
5.1 Global Purinergic Receptor Antagonists Historic Market Size by Application (2018-2023)
5.2 Global Purinergic Receptor Antagonists Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Purinergic Receptor Antagonists Market Size (2018-2029)
6.2 North America Purinergic Receptor Antagonists Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Purinergic Receptor Antagonists Market Size by Country (2018-2023)
6.4 North America Purinergic Receptor Antagonists Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Purinergic Receptor Antagonists Market Size (2018-2029)
7.2 Europe Purinergic Receptor Antagonists Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Purinergic Receptor Antagonists Market Size by Country (2018-2023)
7.4 Europe Purinergic Receptor Antagonists Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Purinergic Receptor Antagonists Market Size (2018-2029)
8.2 Asia-Pacific Purinergic Receptor Antagonists Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Purinergic Receptor Antagonists Market Size by Region (2018-2023)
8.4 Asia-Pacific Purinergic Receptor Antagonists Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Purinergic Receptor Antagonists Market Size (2018-2029)
9.2 Latin America Purinergic Receptor Antagonists Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Purinergic Receptor Antagonists Market Size by Country (2018-2023)
9.4 Latin America Purinergic Receptor Antagonists Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Purinergic Receptor Antagonists Market Size (2018-2029)
10.2 Middle East & Africa Purinergic Receptor Antagonists Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Purinergic Receptor Antagonists Market Size by Country (2018-2023)
10.4 Middle East & Africa Purinergic Receptor Antagonists Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Purinergic Receptor Antagonists Introduction
11.1.4 Sanofi Revenue in Purinergic Receptor Antagonists Business (2018-2023)
11.1.5 Sanofi Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Detail
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Purinergic Receptor Antagonists Introduction
11.2.4 Bristol Myers Squibb Revenue in Purinergic Receptor Antagonists Business (2018-2023)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Apotex
11.3.1 Apotex Company Detail
11.3.2 Apotex Business Overview
11.3.3 Apotex Purinergic Receptor Antagonists Introduction
11.3.4 Apotex Revenue in Purinergic Receptor Antagonists Business (2018-2023)
11.3.5 Apotex Recent Development
11.4 Mylan
11.4.1 Mylan Company Detail
11.4.2 Mylan Business Overview
11.4.3 Mylan Purinergic Receptor Antagonists Introduction
11.4.4 Mylan Revenue in Purinergic Receptor Antagonists Business (2018-2023)
11.4.5 Mylan Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Detail
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Purinergic Receptor Antagonists Introduction
11.5.4 AstraZeneca Revenue in Purinergic Receptor Antagonists Business (2018-2023)
11.5.5 AstraZeneca Recent Development
11.6 Chiesi Farmaceutici
11.6.1 Chiesi Farmaceutici Company Detail
11.6.2 Chiesi Farmaceutici Business Overview
11.6.3 Chiesi Farmaceutici Purinergic Receptor Antagonists Introduction
11.6.4 Chiesi Farmaceutici Revenue in Purinergic Receptor Antagonists Business (2018-2023)
11.6.5 Chiesi Farmaceutici Recent Development
11.7 Bayer
11.7.1 Bayer Company Detail
11.7.2 Bayer Business Overview
11.7.3 Bayer Purinergic Receptor Antagonists Introduction
11.7.4 Bayer Revenue in Purinergic Receptor Antagonists Business (2018-2023)
11.7.5 Bayer Recent Development
11.8 Zydus Cadila Healthcare
11.8.1 Zydus Cadila Healthcare Company Detail
11.8.2 Zydus Cadila Healthcare Business Overview
11.8.3 Zydus Cadila Healthcare Purinergic Receptor Antagonists Introduction
11.8.4 Zydus Cadila Healthcare Revenue in Purinergic Receptor Antagonists Business (2018-2023)
11.8.5 Zydus Cadila Healthcare Recent Development
11.9 Sun Pharmaceutical
11.9.1 Sun Pharmaceutical Company Detail
11.9.2 Sun Pharmaceutical Business Overview
11.9.3 Sun Pharmaceutical Purinergic Receptor Antagonists Introduction
11.9.4 Sun Pharmaceutical Revenue in Purinergic Receptor Antagonists Business (2018-2023)
11.9.5 Sun Pharmaceutical Recent Development
11.10 Huahai Pharmaceutical
11.10.1 Huahai Pharmaceutical Company Detail
11.10.2 Huahai Pharmaceutical Business Overview
11.10.3 Huahai Pharmaceutical Purinergic Receptor Antagonists Introduction
11.10.4 Huahai Pharmaceutical Revenue in Purinergic Receptor Antagonists Business (2018-2023)
11.10.5 Huahai Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Purinergic Receptor Antagonists Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of P2Y
Table 3. Key Players of P2X
Table 4. Global Purinergic Receptor Antagonists Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Purinergic Receptor Antagonists Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Purinergic Receptor Antagonists Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Purinergic Receptor Antagonists Market Share by Region (2018-2023)
Table 8. Global Purinergic Receptor Antagonists Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Purinergic Receptor Antagonists Market Share by Region (2024-2029)
Table 10. Purinergic Receptor Antagonists Market Trends
Table 11. Purinergic Receptor Antagonists Market Drivers
Table 12. Purinergic Receptor Antagonists Market Challenges
Table 13. Purinergic Receptor Antagonists Market Restraints
Table 14. Global Purinergic Receptor Antagonists Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Purinergic Receptor Antagonists Market Share by Players (2018-2023)
Table 16. Global Top Purinergic Receptor Antagonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Purinergic Receptor Antagonists as of 2022)
Table 17. Ranking of Global Top Purinergic Receptor Antagonists Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Purinergic Receptor Antagonists Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Purinergic Receptor Antagonists Product Solution and Service
Table 21. Date of Enter into Purinergic Receptor Antagonists Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Purinergic Receptor Antagonists Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Purinergic Receptor Antagonists Revenue Market Share by Type (2018-2023)
Table 25. Global Purinergic Receptor Antagonists Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Purinergic Receptor Antagonists Revenue Market Share by Type (2024-2029)
Table 27. Global Purinergic Receptor Antagonists Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Purinergic Receptor Antagonists Revenue Market Share by Application (2018-2023)
Table 29. Global Purinergic Receptor Antagonists Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Purinergic Receptor Antagonists Revenue Market Share by Application (2024-2029)
Table 31. North America Purinergic Receptor Antagonists Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Purinergic Receptor Antagonists Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Purinergic Receptor Antagonists Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Purinergic Receptor Antagonists Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Purinergic Receptor Antagonists Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Purinergic Receptor Antagonists Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Purinergic Receptor Antagonists Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Purinergic Receptor Antagonists Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Purinergic Receptor Antagonists Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Purinergic Receptor Antagonists Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Purinergic Receptor Antagonists Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Purinergic Receptor Antagonists Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Purinergic Receptor Antagonists Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Purinergic Receptor Antagonists Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Purinergic Receptor Antagonists Market Size by Country (2024-2029) & (US$ Million)
Table 46. Sanofi Company Detail
Table 47. Sanofi Business Overview
Table 48. Sanofi Purinergic Receptor Antagonists Product
Table 49. Sanofi Revenue in Purinergic Receptor Antagonists Business (2018-2023) & (US$ Million)
Table 50. Sanofi Recent Development
Table 51. Bristol Myers Squibb Company Detail
Table 52. Bristol Myers Squibb Business Overview
Table 53. Bristol Myers Squibb Purinergic Receptor Antagonists Product
Table 54. Bristol Myers Squibb Revenue in Purinergic Receptor Antagonists Business (2018-2023) & (US$ Million)
Table 55. Bristol Myers Squibb Recent Development
Table 56. Apotex Company Detail
Table 57. Apotex Business Overview
Table 58. Apotex Purinergic Receptor Antagonists Product
Table 59. Apotex Revenue in Purinergic Receptor Antagonists Business (2018-2023) & (US$ Million)
Table 60. Apotex Recent Development
Table 61. Mylan Company Detail
Table 62. Mylan Business Overview
Table 63. Mylan Purinergic Receptor Antagonists Product
Table 64. Mylan Revenue in Purinergic Receptor Antagonists Business (2018-2023) & (US$ Million)
Table 65. Mylan Recent Development
Table 66. AstraZeneca Company Detail
Table 67. AstraZeneca Business Overview
Table 68. AstraZeneca Purinergic Receptor Antagonists Product
Table 69. AstraZeneca Revenue in Purinergic Receptor Antagonists Business (2018-2023) & (US$ Million)
Table 70. AstraZeneca Recent Development
Table 71. Chiesi Farmaceutici Company Detail
Table 72. Chiesi Farmaceutici Business Overview
Table 73. Chiesi Farmaceutici Purinergic Receptor Antagonists Product
Table 74. Chiesi Farmaceutici Revenue in Purinergic Receptor Antagonists Business (2018-2023) & (US$ Million)
Table 75. Chiesi Farmaceutici Recent Development
Table 76. Bayer Company Detail
Table 77. Bayer Business Overview
Table 78. Bayer Purinergic Receptor Antagonists Product
Table 79. Bayer Revenue in Purinergic Receptor Antagonists Business (2018-2023) & (US$ Million)
Table 80. Bayer Recent Development
Table 81. Zydus Cadila Healthcare Company Detail
Table 82. Zydus Cadila Healthcare Business Overview
Table 83. Zydus Cadila Healthcare Purinergic Receptor Antagonists Product
Table 84. Zydus Cadila Healthcare Revenue in Purinergic Receptor Antagonists Business (2018-2023) & (US$ Million)
Table 85. Zydus Cadila Healthcare Recent Development
Table 86. Sun Pharmaceutical Company Detail
Table 87. Sun Pharmaceutical Business Overview
Table 88. Sun Pharmaceutical Purinergic Receptor Antagonists Product
Table 89. Sun Pharmaceutical Revenue in Purinergic Receptor Antagonists Business (2018-2023) & (US$ Million)
Table 90. Sun Pharmaceutical Recent Development
Table 91. Huahai Pharmaceutical Company Detail
Table 92. Huahai Pharmaceutical Business Overview
Table 93. Huahai Pharmaceutical Purinergic Receptor Antagonists Product
Table 94. Huahai Pharmaceutical Revenue in Purinergic Receptor Antagonists Business (2018-2023) & (US$ Million)
Table 95. Huahai Pharmaceutical Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Purinergic Receptor Antagonists Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Purinergic Receptor Antagonists Market Share by Type: 2022 VS 2029
Figure 3. P2Y Features
Figure 4. P2X Features
Figure 5. Global Purinergic Receptor Antagonists Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Purinergic Receptor Antagonists Market Share by Application: 2022 VS 2029
Figure 7. Heart Disease Case Studies
Figure 8. Stroke Case Studies
Figure 9. Others Case Studies
Figure 10. Purinergic Receptor Antagonists Report Years Considered
Figure 11. Global Purinergic Receptor Antagonists Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Purinergic Receptor Antagonists Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Purinergic Receptor Antagonists Market Share by Region: 2022 VS 2029
Figure 14. Global Purinergic Receptor Antagonists Market Share by Players in 2022
Figure 15. Global Top Purinergic Receptor Antagonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Purinergic Receptor Antagonists as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Purinergic Receptor Antagonists Revenue in 2022
Figure 17. North America Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Purinergic Receptor Antagonists Market Share by Country (2018-2029)
Figure 19. United States Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Purinergic Receptor Antagonists Market Share by Country (2018-2029)
Figure 23. Germany Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Purinergic Receptor Antagonists Market Share by Region (2018-2029)
Figure 31. China Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Purinergic Receptor Antagonists Market Share by Country (2018-2029)
Figure 39. Mexico Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Purinergic Receptor Antagonists Market Share by Country (2018-2029)
Figure 43. Turkey Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Purinergic Receptor Antagonists Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Sanofi Revenue Growth Rate in Purinergic Receptor Antagonists Business (2018-2023)
Figure 46. Bristol Myers Squibb Revenue Growth Rate in Purinergic Receptor Antagonists Business (2018-2023)
Figure 47. Apotex Revenue Growth Rate in Purinergic Receptor Antagonists Business (2018-2023)
Figure 48. Mylan Revenue Growth Rate in Purinergic Receptor Antagonists Business (2018-2023)
Figure 49. AstraZeneca Revenue Growth Rate in Purinergic Receptor Antagonists Business (2018-2023)
Figure 50. Chiesi Farmaceutici Revenue Growth Rate in Purinergic Receptor Antagonists Business (2018-2023)
Figure 51. Bayer Revenue Growth Rate in Purinergic Receptor Antagonists Business (2018-2023)
Figure 52. Zydus Cadila Healthcare Revenue Growth Rate in Purinergic Receptor Antagonists Business (2018-2023)
Figure 53. Sun Pharmaceutical Revenue Growth Rate in Purinergic Receptor Antagonists Business (2018-2023)
Figure 54. Huahai Pharmaceutical Revenue Growth Rate in Purinergic Receptor Antagonists Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のGnRH受容体拮抗薬市場2022年：市場規模予測（～2028年）
  • ヒスタミンH4受容体のグローバル市場展望 2023年-2029年：GD-48、JNJ-28307474、UR-63325、ZPL-389、その他
  • 膨張歯茎治療の世界市場2023年：ミノサイクリン、クロルヘキシジン、ヨウ素グリセリン
  • チロシンタンパク質ホスファターゼ非受容体タイプ 1のグローバル市場展望 2023年-2029年：AU-2439、CPT-157633、DPM-1001、KQ-791、その他
  • 関節内出血治療の世界市場2023年：手術治療、医療治療
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8630 )"プリン作動性受容体拮抗薬の世界市場2023年：P2Y、P2X" (英文：Global Purinergic Receptor Antagonists Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。